Showing 1 - 4 results of 4 for search 'Gerrit K', query time: 0.03s Refine Results
  1. 1
    18F−Prostate−Specific Membrane Antigen PET/CT imaging for potentially resectable pancreatic cancer (PANSCAN−2): a phase I/II study

    18F−Prostate−Specific Membrane Antigen PET/CT imaging for potentially resectable pancreatic cancer (PANSCAN−2): a phase I/II study by Jisce R. Puik, Thomas T. Poels, Gerrit K. J. Hooijer, Matthijs C. F. Cysouw, Joanne Verheij, Johanna W. Wilmink, Elisa Giovannetti, Geert Kazemier, Arantza Farina Sarasqueta, Daniela E. Oprea-Lager, Rutger-Jan Swijnenburg

    Published 2025-01-01
    Get full text
    Article
  2. 2
    Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study

    Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study by Charlotte I. Stroes, Sybren L. Meijer, Geert-Jan Creemers, Gerrit K.J. Hooijer, Nadia Haj Mohammad, Maartje Los, Marije Slingerland, Geke A.P. Hospers, Annemieke Cats, Laurens V. Beerepoot, Maarten F. Bijlsma, Hanneke W.M. van Laarhoven

    Published 2024-11-01
    Get full text
    Article
  3. 3
    The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma

    The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma by Amber P. van der Zalm, Mark P. G. Dings, Paul Manoukian, Hannah Boersma, Reimer Janssen, Peter Bailey, Jan Koster, Danny Zwijnenburg, Richard Volckmann, Sanne Bootsma, Cynthia Waasdorp, Monique van Mourik, Dionne Blangé, Tom van den Ende, César I. Oyarce, Sarah Derks, Aafke Creemers, Eva A. Ebbing, Gerrit K. Hooijer, Sybren L. Meijer, Mark I. van Berge Henegouwen, Jan Paul Medema, Hanneke W. M. van Laarhoven, Maarten F. Bijlsma

    Published 2024-05-01
    Get full text
    Article
  4. 4
    Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study

    Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study by Lenka N. C. Boyd, Lenka N. C. Boyd, Lenka N. C. Boyd, Lynn E. Nooijen, Lynn E. Nooijen, Lynn E. Nooijen, Mahsoem Ali, Mahsoem Ali, Mahsoem Ali, Jisce R. Puik, Jisce R. Puik, Jisce R. Puik, Jasmine Moustaquim, Stephanie M. Fraga Rodrigues, Stephanie M. Fraga Rodrigues, Stephanie M. Fraga Rodrigues, Robert Broos, Robert Broos, Robert Broos, Ali Belkouz, Laura L. Meijer, Tessa Y. S. Le Large, Tessa Y. S. Le Large, Tessa Y. S. Le Large, Joris I. Erdmann, Gerrit K. J. Hooijer, Michal Heger, Michal Heger, Michal Heger, Hanneke W. M. Van Laarhoven, Hanneke W. M. Van Laarhoven, Eva Roos, Geert Kazemier, Geert Kazemier, Elisa Giovannetti, Elisa Giovannetti, Elisa Giovannetti, Joanne Verheij, Heinz-Josef Klümpen

    Published 2023-10-01
    Get full text
    Article

Search Tools: